VALLI, MAURIZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.538
AS - Asia 1.507
EU - Europa 1.344
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 38
OC - Oceania 2
Totale 5.651
Nazione #
US - Stati Uniti d'America 2.462
CN - Cina 794
SG - Singapore 325
IE - Irlanda 312
UA - Ucraina 185
FI - Finlandia 152
DE - Germania 149
RU - Federazione Russa 137
HK - Hong Kong 136
BR - Brasile 127
VN - Vietnam 111
IT - Italia 105
GB - Regno Unito 86
FR - Francia 82
SE - Svezia 44
CA - Canada 30
IN - India 29
BE - Belgio 20
AR - Argentina 18
IQ - Iraq 15
TR - Turchia 15
CZ - Repubblica Ceca 14
JP - Giappone 14
ZA - Sudafrica 14
BD - Bangladesh 12
MX - Messico 12
IR - Iran 11
NL - Olanda 11
PL - Polonia 10
ES - Italia 9
EC - Ecuador 8
CO - Colombia 7
ID - Indonesia 7
PK - Pakistan 6
CL - Cile 5
IL - Israele 5
VE - Venezuela 5
GP - Guadalupe 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
NI - Nicaragua 4
PT - Portogallo 4
PY - Paraguay 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
CR - Costa Rica 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
PR - Porto Rico 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
LV - Lettonia 2
PA - Panama 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MU - Mauritius 1
NP - Nepal 1
RS - Serbia 1
SR - Suriname 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.614
Città #
Dublin 312
Ashburn 279
Chandler 261
Jacksonville 219
San Jose 196
Dallas 172
Singapore 169
Beijing 163
Nanjing 145
Hong Kong 134
Council Bluffs 110
Boardman 85
Nanchang 70
Ann Arbor 67
Los Angeles 63
Shenyang 58
Changsha 50
Lawrence 49
Medford 49
Princeton 49
Hebei 48
Wilmington 45
Helsinki 43
Lauterbourg 43
Jiaxing 42
New York 40
Ho Chi Minh City 39
Munich 36
Hangzhou 28
Tianjin 27
Hanoi 25
Milan 24
Moscow 22
Santa Clara 22
Buffalo 21
Shanghai 21
Woodbridge 21
Brussels 20
Orem 17
Turku 17
Pavia 16
São Paulo 14
Washington 14
Chicago 13
Johannesburg 13
Tokyo 12
San Francisco 11
Verona 11
Atlanta 10
Denver 10
Toronto 10
Auburn Hills 9
Brooklyn 9
Montreal 9
Redondo Beach 9
Chennai 8
Phoenix 8
Rome 8
Ardabil 7
Brno 7
Frankfurt am Main 7
Norwalk 7
The Dalles 7
Houston 6
London 6
Mexico City 6
Milwaukee 6
Naples 6
Olomouc 6
Sacramento 6
Warsaw 6
Zhengzhou 6
Baghdad 5
Belo Horizonte 5
Boston 5
Guangzhou 5
Manchester 5
Ankara 4
Bogotá 4
Charlotte 4
Curitiba 4
Da Nang 4
Des Moines 4
Haiphong 4
Helena 4
Jinan 4
Managua 4
Nairobi 4
Padova 4
Piscataway 4
Poplar 4
Reconquista 4
Rio de Janeiro 4
Seattle 4
Stockholm 4
Amsterdam 3
Can Tho 3
Carapicuíba 3
Chongqing 3
Columbus 3
Totale 3.696
Nome #
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 198
5-METHYL-PYRROLIDINONE CHITOSAN FILMS AS CARRIRERS FOR BUCCAL ADMINISTRATION OF PROTEINS 182
An in vitro test predictive of bioadhesive properties of chitosan films for buccal application 179
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 179
Bioadhesive films for buccal release of proteins 176
Characterization of protein loaded 5-methyl-pyrrolidinone chitosan films 168
Bioadhesive chitosan films for buccal release of proteins 161
Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix. 156
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 143
Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1. 142
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 141
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 137
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis 135
Dipeptide loaded liposomes in photoaging: evaluation of cellular viability 133
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 133
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 128
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 128
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 122
Diagnosis of vascular Ehlers-Danlos syndrome in Italy: Clinical findings and novel COL3A1 mutations 121
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity. 119
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 118
Identification of the amniotic fluid insulin-like growthfactor binding protein-1 phosphorylation sites andpropensity to proteolysis of the isoforms 118
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis. 116
Evaluation of bioadhesive performance of chitosan derivatives as films for buccal application 113
"In vitro" fibril formation of type I collagen from different sources: biochemical and morphological aspects. 113
Cutaneous metaplastic synovial cyst in Ehlers-Danlos syndrome: report of a second case. 113
Studio delle proprietà bioadesive del chitosano in funzione della veicolazione di farmaci proteici a livello buccale 101
Isolation and characterization of two proteoglycans from bovine tendon 101
Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid. 101
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 97
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 97
Subependymal periventricular heterotopias in a patient with ehlers-danlos syndrome: a new case 96
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 96
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 94
Osteogenesis imperfecta: clinical, biochemical and molecular findings. 91
Cardiac valve disease: an unreported feature in Ehlers Danlos syndrome arthrocalasia type? 91
Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. 89
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine a1(I) 901 substitution in a type-I collagen gene. 89
Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. 88
Gly85 to Val substitution in proa1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion. 87
Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor causes progressively deforming osteogenesis imperfecta with normal type I collagen. 86
Mouse C127 cells transfection with fucosyltransferase Fuc-TIII express masked Lewis X but not Lewis X antigen 82
Human Cells Unable to Express Decoron Produced Disorganized Extracellular Matrix Lacking “Shape Modules” (Interfibrillar Proteoglycan Bridges) 82
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation. 81
Study of factors affecting the determination of total plasma 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate (SBD)-thiol derivatives by liquid chromatography. 77
Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen. 69
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. 68
Severe peripheral joint laxity is a distinctive clinical feature of spondylodysplastic-ehlers-danlos syndrome (Eds)-b4galt7 and spondylodysplastic-eds-b3galt6 63
Osteoblasts extracellular matrix induces vessel like structures through glycosylated collagen I. 53
Totale 5.651
Categoria #
all - tutte 22.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 0 0 3 2 7 9 13 3 34 129
2022/2023798 77 60 2 70 88 74 1 37 353 10 18 8
2023/2024304 25 55 22 37 26 81 4 26 1 7 13 7
2024/2025724 30 55 28 24 17 31 26 29 178 30 112 164
2025/20261.664 150 111 213 171 197 84 318 62 142 132 39 45
2026/2027480 28 90 133 219 10 0 0 0 0 0 0 0
Totale 5.651